SK9612002A3 - Novel therapeutic use of enoxaparin - Google Patents
Novel therapeutic use of enoxaparin Download PDFInfo
- Publication number
- SK9612002A3 SK9612002A3 SK961-2002A SK9612002A SK9612002A3 SK 9612002 A3 SK9612002 A3 SK 9612002A3 SK 9612002 A SK9612002 A SK 9612002A SK 9612002 A3 SK9612002 A3 SK 9612002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- enoxaparin
- study
- rats
- therapeutic use
- hours
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000137A FR2803522B1 (fr) | 2000-01-06 | 2000-01-06 | Nouvelle application therapeutique de l'enoxaparine |
| PCT/FR2001/000014 WO2001049298A2 (fr) | 2000-01-06 | 2001-01-03 | Nouvelle application therapeutique de l"enoxaparine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK9612002A3 true SK9612002A3 (en) | 2002-12-03 |
Family
ID=8845669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK961-2002A SK9612002A3 (en) | 2000-01-06 | 2001-01-03 | Novel therapeutic use of enoxaparin |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1248638B1 (pt) |
| JP (1) | JP2003519185A (pt) |
| KR (1) | KR20020069240A (pt) |
| CN (1) | CN1400905A (pt) |
| AR (1) | AR026804A1 (pt) |
| AT (1) | ATE344671T1 (pt) |
| AU (1) | AU784656B2 (pt) |
| BR (1) | BR0107442A (pt) |
| CA (1) | CA2396178A1 (pt) |
| CZ (1) | CZ20022303A3 (pt) |
| DE (1) | DE60124373T2 (pt) |
| DK (1) | DK1248638T3 (pt) |
| EA (1) | EA006035B1 (pt) |
| EE (1) | EE200200374A (pt) |
| ES (1) | ES2275648T3 (pt) |
| FR (1) | FR2803522B1 (pt) |
| HK (1) | HK1052649A1 (pt) |
| HR (1) | HRP20020573A2 (pt) |
| HU (1) | HUP0204040A3 (pt) |
| IL (1) | IL150477A0 (pt) |
| MX (1) | MXPA02006672A (pt) |
| NO (1) | NO20023243D0 (pt) |
| NZ (1) | NZ520283A (pt) |
| PL (1) | PL357192A1 (pt) |
| PT (1) | PT1248638E (pt) |
| SK (1) | SK9612002A3 (pt) |
| UA (1) | UA75587C2 (pt) |
| WO (1) | WO2001049298A2 (pt) |
| YU (1) | YU51802A (pt) |
| ZA (1) | ZA200205415B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2007003121A1 (es) * | 2006-10-30 | 2008-05-16 | Aventis Pharma Sa | Uso de una dosis de 40 mg de enoxaparina sodica como minimo para tratar a un paciente de 65 anos de edad o mayor con ictus isquemico agudo o una puntuacion media de 10 o superior en la escala de nih para el ictus. |
| ITMI20091445A1 (it) * | 2009-08-07 | 2011-02-08 | Inalco S P A A Socio Unico | Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5442594A (en) * | 1992-10-13 | 1994-05-09 | Virginia Commonwealth University | Use of non-anticoagulant heparin for treating ischemia/reperfusion injury |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
-
2000
- 2000-01-06 FR FR0000137A patent/FR2803522B1/fr not_active Expired - Fee Related
-
2001
- 2001-01-03 CN CN01803471A patent/CN1400905A/zh active Pending
- 2001-01-03 CA CA002396178A patent/CA2396178A1/fr not_active Abandoned
- 2001-01-03 SK SK961-2002A patent/SK9612002A3/sk not_active Application Discontinuation
- 2001-01-03 EA EA200200750A patent/EA006035B1/ru not_active IP Right Cessation
- 2001-01-03 ES ES01903859T patent/ES2275648T3/es not_active Expired - Lifetime
- 2001-01-03 HU HU0204040A patent/HUP0204040A3/hu unknown
- 2001-01-03 IL IL15047701A patent/IL150477A0/xx unknown
- 2001-01-03 PL PL01357192A patent/PL357192A1/xx unknown
- 2001-01-03 DK DK01903859T patent/DK1248638T3/da active
- 2001-01-03 JP JP2001549666A patent/JP2003519185A/ja active Pending
- 2001-01-03 DE DE60124373T patent/DE60124373T2/de not_active Expired - Fee Related
- 2001-01-03 YU YU51802A patent/YU51802A/sh unknown
- 2001-01-03 AT AT01903859T patent/ATE344671T1/de not_active IP Right Cessation
- 2001-01-03 KR KR1020027008754A patent/KR20020069240A/ko not_active Application Discontinuation
- 2001-01-03 PT PT01903859T patent/PT1248638E/pt unknown
- 2001-01-03 MX MXPA02006672A patent/MXPA02006672A/es active IP Right Grant
- 2001-01-03 BR BR0107442-3A patent/BR0107442A/pt not_active IP Right Cessation
- 2001-01-03 EP EP01903859A patent/EP1248638B1/fr not_active Expired - Lifetime
- 2001-01-03 AU AU31830/01A patent/AU784656B2/en not_active Ceased
- 2001-01-03 NZ NZ520283A patent/NZ520283A/en unknown
- 2001-01-03 EE EEP200200374A patent/EE200200374A/xx unknown
- 2001-01-03 WO PCT/FR2001/000014 patent/WO2001049298A2/fr not_active Application Discontinuation
- 2001-01-03 CZ CZ20022303A patent/CZ20022303A3/cs unknown
- 2001-01-05 AR ARP010100054A patent/AR026804A1/es unknown
- 2001-03-01 UA UA2002076399A patent/UA75587C2/uk unknown
-
2002
- 2002-07-04 NO NO20023243A patent/NO20023243D0/no not_active Application Discontinuation
- 2002-07-04 HR HR20020573A patent/HRP20020573A2/hr not_active Application Discontinuation
- 2002-07-05 ZA ZA200205415A patent/ZA200205415B/xx unknown
-
2003
- 2003-07-09 HK HK03104944.6A patent/HK1052649A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4245192B2 (ja) | ３，０００〜１４，０００ダルトンの平均分子量を有するｐｖｐからなる組成物 | |
| WO2007069727A1 (ja) | 急性腎不全の予防または治療剤 | |
| EP1703913B1 (en) | Use of ribose in recovery from anaesthesia | |
| JP3396953B2 (ja) | 網膜疾患予防・治療剤 | |
| AU2762792A (en) | Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow | |
| KR20120030598A (ko) | 할로겐화된 휘발성 마취제의 정맥내 투여에 의한 심장보호 및 신경보호방법 | |
| SK9612002A3 (en) | Novel therapeutic use of enoxaparin | |
| DE3586993T2 (de) | Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln. | |
| US20010041686A1 (en) | Novel therapeutic application of enoxaparin | |
| JPH10502652A (ja) | 一時的な局在性虚血により惹起される再灌流障害の処置のための、（Ｓ）−アダマンチル−Ｌ−メチオニン（ＳＡＭｅ）及びその生理学的に認容性の塩の使用 | |
| Albright et al. | Oncotic therapy of experimental cerebral oedema | |
| Hollmann et al. | Effects of calcium and magnesium pretreatment on hyperkalaemic cardiac arrest in rats | |
| PL206008B1 (pl) | Zastosowanie konkretnej dawki pentasacharydu, O-metylo-(2-deoksy-2-sulfoamino -6-O-sulfo-α-D-glukopiranozylo) -(1→4)-O-(β-D-glukopiranozylo kwasu uronowego) -(1→4)-O-(2-deoksy-2-sulfoamino-3,6-di-O-sulfo-α-D-glukopiranozylo)-(1→4)-O- (2-O-sulfo-α-L-idopiranozylo kwasu uronowego) - (1→4) -2-deoksy-2-sulfoamino-6-O-sulfo-α-D-glukopiranozydu w leczeniu ostrych zespołów wieńcowych | |
| Lowy et al. | Clinical and preclinical trials of isolated liver perfusion for advanced liver tumors: Primary liver tumors | |
| Alzahrani et al. | Tranexamic Acid Intravenous Overdose Administration in Primary Total Knee Arthroplasty: Case Report | |
| MX2015002646A (es) | Otamixaban para uso en el tratamiento de sindrome coronario agudo sin elevacion de st en pacientes programados para ser sometidos a injerto de bypass de arteria coronaria. | |
| JP3381198B2 (ja) | １，４−ジヒドロピリジンの糖尿病における使用 | |
| JPH11140103A (ja) | 脊髄潅流液 | |
| AU672364B2 (en) | Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins | |
| WO1994004017A2 (en) | New method of treatment | |
| WO2001097812A1 (fr) | Preparations pharmaceutiques contenant des composes tetracycliques | |
| SK120299A3 (en) | Use of human 'alpha'1-acid glycoprotein for producing a pharmaceutical preparation | |
| WO1995019789A1 (fr) | Agent de prevention ou de traitement des troubles moteurs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |